NSE filing, NSE: SUNREST. Summary written from the filing by ALFA Finder's alert engine.
Sunrest Lifescience Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹28.75 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹4.12 Cr
- P/E (TTM)
- 7.0×Sector 46.5×
- Promoter holding
- 53.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunrest Lifescience Ltd
All →Sunrest Lifescience Board Meeting Outcome
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.
Sunrest Lifescience Capital Structure Change
Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.
Sunrest Lifescience Business Update
Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.
- Value
- ₹9.22 Cr
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.
- Value
- ₹10.00 Cr
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience Limited will hold its Annual General Meeting on September 07, 2026. The company has also filed its Annual Report for the financial year 2025-26.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.